S&P 500   3,231.86 (-3.17%)
DOW   28,039.88 (-3.29%)
QQQ   221.88 (-3.64%)
AAPL   300.43 (-4.03%)
MSFT   171.94 (-3.72%)
GOOGL   1,420.18 (-4.27%)
AMZN   2,005.15 (-4.33%)
NVDA   273.87 (-6.87%)
BABA   204.40 (-3.85%)
MU   54.68 (-4.05%)
GE   11.89 (-2.94%)
TSLA   835.90 (-7.23%)
AMD   49.06 (-7.92%)
T   38.37 (-0.47%)
ACB   1.55 (-7.19%)
F   7.64 (-3.17%)
NFLX   368.22 (-3.12%)
BAC   32.65 (-4.98%)
GILD   72.21 (+3.60%)
S&P 500   3,231.86 (-3.17%)
DOW   28,039.88 (-3.29%)
QQQ   221.88 (-3.64%)
AAPL   300.43 (-4.03%)
MSFT   171.94 (-3.72%)
GOOGL   1,420.18 (-4.27%)
AMZN   2,005.15 (-4.33%)
NVDA   273.87 (-6.87%)
BABA   204.40 (-3.85%)
MU   54.68 (-4.05%)
GE   11.89 (-2.94%)
TSLA   835.90 (-7.23%)
AMD   49.06 (-7.92%)
T   38.37 (-0.47%)
ACB   1.55 (-7.19%)
F   7.64 (-3.17%)
NFLX   368.22 (-3.12%)
BAC   32.65 (-4.98%)
GILD   72.21 (+3.60%)
S&P 500   3,231.86 (-3.17%)
DOW   28,039.88 (-3.29%)
QQQ   221.88 (-3.64%)
AAPL   300.43 (-4.03%)
MSFT   171.94 (-3.72%)
GOOGL   1,420.18 (-4.27%)
AMZN   2,005.15 (-4.33%)
NVDA   273.87 (-6.87%)
BABA   204.40 (-3.85%)
MU   54.68 (-4.05%)
GE   11.89 (-2.94%)
TSLA   835.90 (-7.23%)
AMD   49.06 (-7.92%)
T   38.37 (-0.47%)
ACB   1.55 (-7.19%)
F   7.64 (-3.17%)
NFLX   368.22 (-3.12%)
BAC   32.65 (-4.98%)
GILD   72.21 (+3.60%)
S&P 500   3,231.86 (-3.17%)
DOW   28,039.88 (-3.29%)
QQQ   221.88 (-3.64%)
AAPL   300.43 (-4.03%)
MSFT   171.94 (-3.72%)
GOOGL   1,420.18 (-4.27%)
AMZN   2,005.15 (-4.33%)
NVDA   273.87 (-6.87%)
BABA   204.40 (-3.85%)
MU   54.68 (-4.05%)
GE   11.89 (-2.94%)
TSLA   835.90 (-7.23%)
AMD   49.06 (-7.92%)
T   38.37 (-0.47%)
ACB   1.55 (-7.19%)
F   7.64 (-3.17%)
NFLX   368.22 (-3.12%)
BAC   32.65 (-4.98%)
GILD   72.21 (+3.60%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 ChemoCentryxArQuleZogenixAmicus TherapeuticsKaruna Therapeutics
SymbolNASDAQ:CCXINASDAQ:ARQLNASDAQ:ZGNXNASDAQ:FOLDNASDAQ:KRTX
Price Information
Current Price$47.30$20.00$29.10$10.29$88.68
52 Week RangeBuyHoldBuyBuyBuy
Analyst Ratings
Consensus RecommendationBuyHoldBuyBuyBuy
Consensus Price Target$50.00$17.50$59.20$20.98$110.13
% Upside from Price Target5.71% upside-12.50% downside103.44% upside104.01% upside24.18% upside
Trade Information
Market Cap$2.75 billion$2.42 billion$1.33 billion$2.63 billion$2.19 billion
Beta2.42.492.011.54N/A
Average Volume441,8005,269,0801,458,7272,779,732286,939
Sales & Book Value
Annual Revenue$42.88 million$25.76 million$9.82 million$91.25 millionN/A
Price / Sales64.0393.85131.1628.72N/A
CashflowN/AN/AN/AN/AN/A
Price / CashN/AN/AN/AN/AN/A
Book Value$0.29 per share$0.72 per share$12.46 per share$1.81 per shareN/A
Price / Book163.1027.782.345.68N/A
Profitability
Net Income$-37,970,000.00$-15,480,000.00$-123,910,000.00$-348,990,000.00N/A
EPS($0.76)($0.16)($3.23)($1.33)N/A
Trailing P/E RatioN/AN/AN/AN/A0.00
Forward P/E RatioN/AN/AN/AN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net Margins-143.30%-805.61%N/A-216.02%N/A
Return on Equity (ROE)-88.76%-33.10%-31.44%-62.61%N/A
Return on Assets (ROA)-23.42%-26.87%-23.59%-36.26%N/A
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.32%0.08%0.04%0.36%N/A
Current Ratio3.12%8.27%3.00%6.20%106.93%
Quick Ratio3.12%8.27%3.00%6.10%106.93%
Ownership Information
Institutional Ownership Percentage68.21%74.63%N/AN/A56.15%
Insider Ownership Percentage12.20%13.80%4.40%2.50%N/A
Miscellaneous
Employees76369050813
Shares Outstanding58.05 million120.87 million44.26 million254.81 million23.41 million
Next Earnings Date3/9/2020 (Estimated)3/5/2020 (Estimated)2/27/2020 (Estimated)3/2/2020 (Confirmed)2/27/2020 (Estimated)
OptionableOptionableOptionableOptionableOptionableNot Optionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel